Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer

Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer

Objective: The standard therapy after failure of the initial non-first line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in advanced non-small cell lung cancer (NSCLC) has not yet been established. The aim of the current study was to identify whether the 2 TKI trea...

Full description

Bibliographic Details
Main Authors: Fang Wang, Gui-fang Guo, Hui-juan Qiu, Wen-zhuo He, Fei-fei Zhou, Xu-xian Chen, Pi-li Hu
Format: Article
Language:English
Published: China Anti-Cancer Association 2012-03-01
Series:Cancer Biology & Medicine
Subjects:
lung neoplasm
chemotherapy
survival analysis
erlotinib
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/7/581

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/7/581

Similar Items